Achieving consensus over the assessment of clinical signs in eczema trials
説明
Background Eczema (syn. atopic dermatitis, atopic eczema) is a chronic, itchy, skin disease that commonly starts in childhood. Over 500 randomised controlled trials of eczema treatment have been conducted, but a core outcome set is lacking, leading to inefficiency and waste. The Harmonizing Outcome Measures for Eczema (HOME) initiative seeks to agree a core set of outcomes for future research, and has previously agreed key outcome domains: clinical signs, patient-reported symptoms, quality of life and long-term control.
収録刊行物
-
- Trials
-
Trials 16 2015-05-29
Springer Science and Business Media LLC
